News
2021.07.05

Zenshine Receives US FDA IND Approval to Initiate Clinical Trial for ZX-4081

View More
2021.06.06

Zenshine Pharma Announces Completion of Series A+ Financing

View More
2021.09.03

Zenshine Announced Dr. Xiaoli Qin as Chief Science Officer

View More
2021.04.15

Zenshine Pharma releases four new research results at the AACR 2021

View More
2021.02.23

The first patient received ZX-101A treatment in the United States

View More
2021.02.23

Zenshine Pharma will present important research results at the AACR 2021

View More